Referral for high risk breast specialty evaluation: Consider referral to breast specialist to discuss primary risk reduction interventions.
These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with a genetic marker or syndrome associated with increased risk of breast cancer, may derive more benefit than harm from risk-reducing medications.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskReferralGenetic)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskReferralCode)
reasonCode[0].coding[0]: (HighRiskReferralReason)
|
Referral for high risk breast specialty evaluation: Consider referral to breast specialist to discuss primary risk reduction interventions.
These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with a history of chest radiotherapy, may derive more benefit than harm from risk-reducing medications.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskReferralChestXRT)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskReferralCode)
reasonCode[0].coding[0]: (HighRiskReferralReason)
|
Referral for high risk breast specialty evaluation: Consider referral to breast specialist to discuss primary risk reduction interventions.
These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with a history of past atypical biopsy results, may derive more benefit than harm from risk-reducing medications.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskReferralAtypicalBiopsy)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskReferralCode)
reasonCode[0].coding[0]: (HighRiskReferralReason)
|
Referral for high risk breast specialty evaluation: Refer to high risk breast specialist to discuss primary risk reduction interventions.
These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with at least a 3% risk for breast cancer in the next 5 years, are likely to derive more benefit than harm from risk-reducing medications.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskReferral5YRiskHigh)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskReferralCode)
reasonCode[0].coding[0]: (HighRiskReferralReason)
|
Consider referral for high risk breast specialty evaluation: Consider referral to breast specialist to discuss primary risk reduction interventions.
These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskReferral5YRiskHigherThanAverage)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/HighRiskSpecialtyReferralRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskReferralCode)
reasonCode[0].coding[0]: (HighRiskReferralReason)
|
Shared decision making for high risk specialty referral based on life expectancy: Patient may not be a candidate for chemoprevention if estimated life expectancy is < 10 years.
Factors that may impact this estimation should be considered prior to referral. A validated tool such as www.eprognosis.com can help guide decision making.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsConsiderLifeExpectancy)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/CommunicateSDMConsiderLifeExpectancy|1.0.0
Dynamic Values:
code.coding[0]: (ConsiderLifeExpectancyCode)
reasonCode[0].coding[0]: (ConsiderLifeExpectancyReason)
|
Perform 5 year risk assessment: A 5 year risk assessment, either informal or formal using a validated instrument, will help determine if the patient may benefit from referral for high risk breast specialty evaluation.
Women at higher than average 5 year risk may be candidates for referral to breast specialist to discuss primary risk reduction interventions. These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance.
If:
Applicability:
(CheckIsIncludedAndNotExcluded)
Applicability:
(ExistsHighRiskAssessment)
Then:
Informal 5 year risk assessment:
Perform assessment based on personal risk factors conferring increased risk of breast cancer.
These may include: increasing age, younger age at menarche, older age at first live birth, nulliparity/lower parity, number of prior breast biopsies, heterogeneously and/or extremely dense breasts.
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/5YearRiskAssessmentRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskAssessmentCode)
reasonCode[0].coding[0]: (HighRiskAssessmentReason)
|
5 year risk assessment instrument:
The NCI Breast Cancer Risk Assessment Tool and the Breast Cancer Surveillance Consortium Risk Calculator are based on models tested in US populations and are publicly available for clinicians and patients to use.
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/5YearRiskAssessmentRequest|1.0.0
Dynamic Values:
code.coding[0]: (HighRiskAssessmentToolCode)
reasonCode[0].coding[0]: (HighRiskAssessmentToolReason)
|
|